14th week of 2009 patent applcation highlights part 33 |
Patent application number | Title | Published |
20090087329 | Compressor Having Improved Valve Plate - A compressor may include a compressor body defining a compression cylinder, a compressor head coupled to the compressor body, and a valve plate assembly disposed between the compressor head and the compressor body. The valve plate assembly may include a first valve plate formed as a unitary casting and defining a suction chamber exposed to a suction pressure region of the compressor. | 2009-04-02 |
20090087330 | FLUID PUMP - A pump is disclosed, having a pumping chamber in the rotor. The rotor is rotatable between first, second, third and fourth positions. When the rotor is in the first position, an inlet cam assembly displaces a piston to draw fluid into the pumping chamber via a first housing inlet. When the rotor is in the second position, an outlet cam assembly displaces the piston to expel fluid out of the pumping chamber via a first housing outlet. When the rotor is in the third position, the inlet cam lobe assembly displaces the piston to draw fluid into the pumping chamber via a second housing inlet. When the rotor is in the fourth position, the outlet cam assembly displaces the piston to expel fluid out of the pumping chamber via a second housing outlet. A method of pumping fluid is also disclosed. | 2009-04-02 |
20090087331 | Scroll type fluid machine - This invention provides a scroll type fluid machine which can simultaneously realize the stabilization of the behavior in the rotational direction of an orbiting scroll and the reduction in the manufacturing cost by the ease of holding a grease. In the scroll type fluid machine, three pairs of rotation prevention mechanisms are provided between a casing and an orbiting scroll. The rotation prevention mechanism is constituted of first and second ball coupling mechanisms having a function different from each other. The first ball coupling mechanism supports the thrust load of the orbiting scroll. Meanwhile, the second ball coupling mechanism supports the rotation force of the orbiting scroll. | 2009-04-02 |
20090087332 | Compressor Having Improved Sealing Assembly - A compressor may include a shell, a bearing housing assembly located within and secured to the shell, a compression mechanism supported on the bearing housing assembly, a partition extending over the compression mechanism, and an annular seal assembly. The partition may be fixed to the shell and may abut an axial end surface of the bearing housing assembly to control a maximum axial distance between the partition and the compression mechanism. The annular seal may be sealingly engaged with the compression mechanism and the bearing housing assembly and may have a generally L-shaped cross-section including a first leg extending generally laterally between the compression mechanism and the partition. The first leg may have an axial thickness that is greater than the maximum axial distance. | 2009-04-02 |
20090087333 | Gerotor pump - A gerotor pump comprises a rotor chamber having a longitudinally extending central axis, an outer rotor rotatable in the rotor chamber with a radial clearance between an outer periphery of the outer rotor and the rotor chamber, an inner rotor rotatable in the outer rotor and cooperably engageable therewith to define a plurality of pumping chambers having respective volumes that vary when, in use, the inner rotor rotates relative to the outer rotor. The inner rotor is rotatable about an axis of rotation spaced from the central axis and contained in a first plane that contains the central axis and the rotor chamber is configured such that the radial clearance in at least one direction in the first plane is greater than at least one radial clearance in a second plane that extends perpendicular to the first plane and contains the central axis. | 2009-04-02 |
20090087334 | Sliding Vane Compression and Expansion Device - A sliding vane compression and expansion device for both cryogenic and normal refrigeration cycles, including the production of liquefied natural gas, is disclosed herein. The device can operate in extreme conditions of pressure and temperature, and incorporates replaceable wear elements as well as functional design elements into a sliding vane device to permit processing of a wide variety of gases (for example, but not limited to, methane, nitrogen, oxygen, argon, etc.), liquids and other media under very extreme conditions, including, but not limited to, super-heated steam, cryogenic liquids, bi-phase gas/liquids (wherein both gaseous and liquid media co-exist or are created in the same area), plasma media, semi-solids and powders. | 2009-04-02 |
20090087335 | FIRE RESISTANT STEEL AND METHOD OF PRODUCTION OF SAME - The present invention provides first resistant steel superior in fire resistance having less variation in material quality and exhibiting a yield strength of ⅔ or more of that at ordinary temperature even at 600° C. and a method of production of the same, that is, fire resistant steel characterized by containing, by mass %, C: 0.01 to 0.03%, Mn: 0.2 to 1.7%, Si: 0.5% or less, Cu: 0.7 to 2%, Mo: 0.8% or less, Nb: 0.01 to 0.3%, Ti: 0.005 to 0.03%, N: 0.006% or less, B: 0.0003 to 0.003%, V: 0.2% or less, Cr: 1% or less, Al: 0.1% or less, P: 0.03% or less, and S: 0.02% or less, containing Ni by mass ratio of Ni/Cu of 0.6 to 0.9, and comprising a balance of Fe and unavoidable impurities, and having a yield strength at 600° C. of 60% of the yield strength at 21° C. | 2009-04-02 |
20090087336 | High-carbon steel wire rod of high ductility - A high-carbon steel wire rod of high ductility for steel cord and the like is provided that experiences little breakage during drawing. The high-carbon steel wire rod of high ductility is a high-carbon steel wire rod fabricated by hot rolling that that has a carbon content of 0.7 mass % or greater, wherein 95% or greater of the wire rod metallographic structure is pearlite structure and the maximum pearlite block size of pearlite at the core of the hot-rolled wire rod is 65 μm or less. The high-carbon steel wire rod of high ductility has a tensile strength in a range of {248+980×(C mass %)}±40 MPa} and a reduction of area of {72.8−40×(C mass %) %} or greater. The high-carbon steel wire rod of high ductility is characterized in that the average pearlite block size at the core of the hot-rolled wire rod constituted by ferrite grain boundaries of an orientation difference of 9 degrees or greater as measured with an EBSP analyzer is 10 μm or greater and 30 μm or less. | 2009-04-02 |
20090087337 | Case-hardening steel excellent in cold forgeability and low carburization distortion property - This invention provides a case-hardening steel excellent in cold forgeability and low carburization distortion property that exhibits low deformation resistance and high limit compressibility when cold, namely, a case-hardening steel excellent in cold forgeability and low carburization distortion property comprising, in mass %, C: 0.07% to 0.3%, Si: 0.01% to 0.15%, Mn: 0.1% to 0.7%, P: 0.03% or less, S: 0.002% to 0.10%, Al: 0.01% to 0.08%, Cr: 0.7% to 1.5%, Ti: 0.01% to 0.15%, B: 0.0005% to 0.005%, N: 0.008% or less, and the balance of Fe and unavoidable impurities, and having a metallographic structure comprising 65% or greater of ferrite and 15% or less of bainite. | 2009-04-02 |
20090087338 | Nickel base super alloy - A nickel base superalloy consisting of 20 to 40 wt % cobalt, 10 to 15 wt % chromium, 3 to 6 wt % molybdenum, 0 to 5 wt % tungsten, 2.5 to 4 wt % aluminium, 3.4 to 5 wt % titanium, 1.35 to 2.5 wt % tantalum, 0 to 2 wt % niobium, 0.5 to 1 wt % hafnium, 0 to 0.1 wt % zirconium, 0.01 to 0.05 wt % carbon, 0.01 to 0.05 wt % boron, 0 to 2 wt % silicon and the balance nickel plus incidental impurities. The gamma prime phase comprises (Ni/Co) | 2009-04-02 |
20090087339 | METHOD FOR FORMING RUTHENIUM COMPLEX FILM USING Beta-DIKETONE-COORDINATED RUTHENIUM PRECURSOR - A method for depositing a thin ruthenium (Ru) film on a substrate in a reaction chamber, comprising: step (i) of supplying at least one type of gas of a ruthenium precursor being a β-diketone-coordinated ruthenium complex and causing the gas to be adsorbed to the substrate in the reaction chamber; step (ii) of supplying a reducing gas into the reaction chamber and exciting the reducing gas, or supplying an excited reducing gas into the reaction chamber, in order to activate the ruthenium precursor adsorbed to the substrate; and step (iii) of repeating steps (i) and (ii) to form a thin ruthenium film on the substrate. | 2009-04-02 |
20090087340 | COPPER-BASED BRAZING ALLOY AND BRAZING PROCESS - The invention proposes a brazing alloy, which can be produced in particular as a homogenous, ductile, amorphous brazing foil and consists of 2 to 20 atom % of nickel, 2 to 12 atom % of tin, 0.5 to 5.0 atom % of zinc, 6 to 16 atom % of phosphorus, remainder copper and incidental impurities. The total amount of copper, nickel, tin and zinc is between 80 and 95 atom %. The addition of more than 0.5 atom % of zinc produces excellent resistance to surface oxidation in air and/or atmospheric humidity. These brazing alloys can be used to produce excellent brazed joints. | 2009-04-02 |
20090087341 | Reinforced aluminum alloy with high electrical and thermal conductivity and its manufacturing process thereof - A reinforced aluminum alloy with high electric and thermal conductivity of the present invention has the weight percentage below: Mg 0.61˜0.65%, Si 0.4˜0.45%, rare earth elements 0.21˜0.3%, B 0.03˜0.10% and the balances essentially Al and unavoidable impurities. The reinforced aluminum alloy enhanced the containing of Mg and Si elements compared to the conventional aluminum alloy such as 6063, and controlled the containing of the Mg and Si in a certain relatively narrower range so as to control the desired quality of the aluminum alloy. At the same time, a Ce of the rare earth elements and B element are added into the aluminum alloy and completely solid melted the added alloys to the aluminum alloy. It is not only remaining the strength of the aluminum alloy, but also increasing the electric and thermal conductivity. | 2009-04-02 |
20090087342 | DEVICE AND METHODS FOR PROCESSING BLOOD IN EXTRACORPOREAL CIRCULATION - A device for treating blood in an extracorporeal blood circuit, the device including a centrifugal pump provided with a transparent enclosure that is connected, by means of an inlet duct, to the outlet of a venous reservoir, the venous reservoir having an inlet that is connected to receive blood from a patient. The transparent enclosure of the pump is connected monolithically to the base of a structure that comprises a heat exchanger and an oxygenator. The structure also supports monolithically, at the peripheral region, an arterial filter that receives the blood in output from the oxygenator and is provided with a connector for coupling to an arterial line for return of the blood to the patient. | 2009-04-02 |
20090087343 | GRIPPING TOOL, DOSAGE TOOL AND TOOL SUPPORT FOR AN AUTOMATIC LABORATORY MACHINE - Gripping tool for automatic laboratory machines, with gripping appliances for gripping vessels, an appliance for converting and/or transferring of movements, the power take-off of which is coupled with the gripping appliances in order to drive them, a coupling appliance for detachable connection with a drive appliance of a tool support of an automatic laboratory machine, which is coupled with the drive of the appliance for converting and/or transferring in order to drive it, and a mounting appliance for detachable mounting of the gripping tool on the tool support of the automatic laboratory machine, while the coupling appliance is connected with the drive appliance of the tool support. | 2009-04-02 |
20090087344 | Small size gene analysis apparatus - By the conventional technique for dispensing more than one reagents accurately, the system is complicated and thus a compact and inexpensive system is difficult to realize. In the present invention, the pressurized dispensing system utilizing a capillary is realized, and in addition, in order to reduce the leakage of reagents different from the reagent dispensed, by forming air layers at the tips of the capillaries after dispensing, a compact, simple, inexpensive analysis apparatus is realized. | 2009-04-02 |
20090087345 | DISK FOR LIQUID SAMPLE ANALYSIS - A disk for liquid sample analysis that has means for detecting any chemical reaction between liquid sample and reagent, and that among others, enhances the accuracy of detecting of components of the liquid sample through “rapidly and homogeneously” dissolving of a solid reagent in the liquid sample. In particular, there is provided a disk for liquid sample analysis comprising one or two or more chambers created in a disk-shaped member and a flow channel for inter-chamber connection, wherein a porous body is disposed in at least one of the chambers, and wherein the porous body bears a reagent capable of reacting with a specified component of the liquid sample. On this disk for liquid sample analysis, the liquid sample can be moved by centrifugal force by rotation and capillary force occurring in the chambers and flow channel. | 2009-04-02 |
20090087346 | Method for Harvesting Nanoparticles and Sequestering Biomarkers - Capture particles for harvesting analytes from solution and methods for using them are described. The capture particles are made up of a polymeric matrix having pore size that allows for the analytes to enter the capture particles. The pore size of the capture particles are changeable upon application of a stimulus to the particles, allowing the pore size of the particles to be changed so that analytes of interest remain sequestered inside the particles. The polymeric matrix of the capture particles are made of co-polymeric materials having a structural monomer and an affinity monomer, the affinity monomer having properties that attract the analyte to the capture particle. The capture particles may be used to isolate and identify analytes present in a mixture. They may also be used to protect analytes which are typically subject to degradation upon harvesting and to concentrate low an analyte in low abundance in a fluid. | 2009-04-02 |
20090087347 | Sensor package with an interim auto-calibration circuit - An interim auto-calibration circuit or label adapted to be used with a sensor package. The sensor package is adapted to be used with first and second instruments to determine the analyte concentration of fluid sample. The instruments are different and include respective first and second plurality of pins that are in different patterns. The sensor package comprises a plurality of electrical connections that includes a plurality of contact areas. The contact areas have a first and second contact sections being shorted together. The first contact sections are adapted to contact a respective one of the first pins. The second contact sections are adapted to contact a respective one of the second pins. The electrical connections assist in conveying information corresponding to the test sensors. The information is adapted to be utilized by the first and the second instruments to auto-calibrate for the test sensors. | 2009-04-02 |
20090087348 | SENSOR APPLICATIONS - A sensor that includes an assembly having a flexible base material and a flexible material layer formed on the flexible base material. Both the flexible base material and the flexible material layer have shrinkable and/or stretchable properties. The flexible base material may include a shrinkable polymer (e.g. PVC/PET or “shrink wrap”), which may shrink up to 500%. The flexible base material may include a stretchable polymer (e.g. Mylar), which may be stretched by at least 1000%. These stretchable and shrinkable properties may be exhibited without substantial functional degradation of either the flexible base material and/or the flexible material layer. | 2009-04-02 |
20090087349 | HYDROGEN IODIDE MANUFACTURING METHOD AND HYDROGEN IODIDE MANUFACTURING APPARATUS - A hydrogen iodide manufacturing method which includes a step of producing aqueous solution of hydrogen iodide and sulfuric acid by causing iodine-containing aqueous solution and sulfur dioxide to react with each other in a pressurized condition. The pressurized condition may be of not lower than 0.1 MPa in gauge pressure. The method may further include: a separation step of adding iodine to the aqueous solution of hydrogen iodide and separating an upper phase containing sulfuric acid relatively to a large extent and a lower phase containing hydrogen iodide relatively to a large extent; and a step of producing hydrogen iodide by adding sulfur dioxide to the upper phase in a pressurized condition and extracting the produced hydrogen iodide to the lower phase. | 2009-04-02 |
20090087350 | OIL-SMOKE EXTRACTOR - The present invention relates to an oil-smoke extractor including a housing defining a number of air holes, a bottom plate detachably secured to the housing and a sterilization and deodorization device seated in a receiving space jointly defined by the housing and the bottom plate. The sterilization and deodorization device includes two lamp supports fixed to the front plate, a pair of lamp holders respectively secured to the lamp supports, at least one nano photocatalyst lamp disposed between the lamp holders, a sterilization lampshade fixed to the lamp supports and an axial flow fan corresponding to one of the air holes in the front plate. When the oil-smoke extractor stops running, the sterilization and deodorization device is powered and begins to work. The kitchen air flows into and out of the oil-smoke extractor via the air slots and the air holes. | 2009-04-02 |
20090087351 | APPARATUS FOR DEPOSITING FLUIDS IN A SOLIDS FLOW OF A SPOUTED BED APPARATUS - An apparatus for introducing fluids into a solids flow of a spouted bed apparatus is provided. The apparatus includes a spray nozzle which opens into a reaction space of the spouted bed apparatus. A lower region of the reaction space is provided with a rectangular cross section for the spouted bed apparatus and is limited in an axial direction by at least one inclined stream return flow wall and an oppositely inclined stream inlet wall with the formation of an axial gap through the reaction space for supplying inlet air. At least one nozzle is also provided for introducing fluid above the gap opens into the reaction space. | 2009-04-02 |
20090087352 | MAT MATERIAL, EXHAUST GAS TREATING APPARATUS, AND MUFFLER - A mat material includes inorganic fibers, a first surface, and a second surface opposite to the first surface. The mat material has plural needle traces formed by performing a needling treatment. The needle traces extend from the first surface toward the second surface and from the second surface toward the first surface. There is no depth in the mat material that the needle traces do not reach. There is substantially no protrusion of a bundle of the inorganic fibers at a position on the second surface that lies on a line extending from each of the needle traces extending from the first surface. There is substantially no protrusion of a bundle of the inorganic fibers at a position on the first surface that lies on a line extending from each of the needle traces extending from the second surface. | 2009-04-02 |
20090087353 | MAT MEMBER, EXHAUST GAS TREATMENT APPARATUS, AND MUFFLING APPARATUS - A mat member includes a base member and a sheet member. The base member includes inorganic fibers and has first and second main surfaces. The sheet member is disposed on at least one of the first and the second main surface. The sheet member has an openings provided on at least a part of a surface of the sheet member. | 2009-04-02 |
20090087354 | EXHAUST TREATMENT DEVICE WITH INDEPENDENT CATALYST SUPPORTS - An exhaust treatment device comprises a housing defining an inlet opening and an outlet opening, a first catalyst brick and a second catalyst brick each having an inlet end and an outlet end, a first insulating support cover, and a second insulating support cover. The first catalyst brick is disposed within a first segment of the housing, and the second catalyst brick is disposed within a second segment of the housing. The first segment has an inner periphery that is not equal to an inner periphery of the second segment. The first and second catalyst bricks each have nonuniform dimensions with respect to one another. The first and second segments of the housing are independently dimensioned in proportion to the first and second catalyst bricks respectively. The first insulating support cover is disposed within the first segment of the housing in a first annular space between an inner surface of the housing and an exterior surface of the first catalyst brick. The second insulating support cover is disposed within the second segment of the housing in a second annular space between the inner surface of the housing and an exterior surface of the second catalyst brick. The first and second insulating support covers are independently dimensioned in proportion to the first and second catalyst bricks respectively. | 2009-04-02 |
20090087355 | Variable plate heat exchangers - A heat exchanger is provided which is capable of sophisticated operations such as undertaking chemical reactions, where particular velocity profiles are required or unusual heat transfer profiles are needed and comprises a unitary heat exchanger comprising a plurality of distinct heat transfer elements or zones containing heat transfer fluid through which a process material flows wherein heat transfer fluid is delivered and removed separately to each heat transfer element or zone. | 2009-04-02 |
20090087356 | Microfluidic Rotary Flow Reactor Matrix - A microfluidic device comprises a matrix of rotary flow reactors. The microfluidic matrix device offers a solution to the “world-to-chip” interface problem by accomplishing two important goals simultaneously: an economy of scale in reagent consumption is achieved, while simultaneously minimizing pipetting steps. N | 2009-04-02 |
20090087357 | MICROCHEMICAL DEVICE AND METHOD FOR FABRICATING THE SAME - In a microchemical device including a plurality of flow channels which feed liquids from at least one fluid supply device into a plurality of reaction zones, each of the plurality of flow channels has a plurality of minute flow channel members each of which has a cross sectional area smaller than that of the reaction zone. Thereby, the fluids are evenly fed into each of the microreaction members. Thus, a microchemical device capable of homogenizing a substance generated on respective reactions can be realized. | 2009-04-02 |
20090087358 | Device for vaporization of fuel - An improved fuel processor for fuel cells is provided whereby the startup time of the processor is less than sixty seconds and can be as low as 30 seconds, if not less. A rapid startup time is achieved by either igniting or allowing a small mixture of air and fuel to react over and warm up the catalyst of an autothermal reformer (ATR). The ATR then produces combustible gases to be subsequently oxidized on and simultaneously warm up water-gas shift zone catalysts. After normal operating temperature has been achieved, the proportion of air included with the fuel is greatly diminished. | 2009-04-02 |
20090087359 | MICRO-REACTOR SYSTEM - A micro-reactor system assembly comprises a stack of at least n process modules ( | 2009-04-02 |
20090087360 | Removal of sodium oxalate from a bayer liquor - The Bayer process uses hot sodium hydroxide solution to obtain pure alumina from bauxite ore. Alumina dissolves, and is then precipitated, and the remaining caustic Bayer liquor can be recycled for use again. However sodium oxalate tends to build up in the recycled liquor, and causes problems. By removing a stream of the liquor, treating it so as to be supersaturated with sodium oxalate, and then subjecting it to ultrasonic irradiation, crystal nuclei are formed. The resultant crystals can then be separated from the liquor. Surprisingly, other organic compounds in solution do not prevent this crystallisation process from being effective. | 2009-04-02 |
20090087361 | PRODUCING NICKEL HYDROXIDE SUITABLE FOR PELLETIZATION WITH IRON-CONTAINING ORE AND FOR STAINLESS STEEL MANUFACTURE - A process for producing a purified nickel hydroxide precipitate from a nickel-containing leach solution with impurities including one or more of the following: manganese, copper, zinc, iron and/or cobalt, so that the purified nickel hydroxide is suitable for pelletization with iron-containing ores and/or stainless steel production, includes treating the leach solution with a base to form a slurry of mixed hydroxide precipitate and low-nickel barren solution, thickening the slurry to form filter cake, washing the filter cake and contacting it with acid to dissolve nickel and other metals to produce a concentrated nickel-containing solution, subjecting the concentrated nickel-containing solution to solvent extraction with an organic acid extractant to remove metals other than nickel from the nickel-containing solution and form a solvent extraction raffinate of purified nickel solution and treating the solvent extraction raffinate with a base to precipitate the purified nickel hydroxide precipitate. | 2009-04-02 |
20090087362 | Cathode Active Material Coated With Fluorine Compound for Lithium Secondary Batteries and Method for Preparing the Same - Disclosed herein is a cathode active material coated with a fluorine compound for lithium secondary batteries. The cathode active material is structurally stable, and improves the charge-discharge characteristics, cycle characteristics, high-voltage characteristics, high-rate characteristics and thermal stability of batteries. | 2009-04-02 |
20090087363 | ENCAPSULATION OF METAL CATALYSTS IN INERT POROUS MATRICES FOR REMOVAL OF CARBON DIOXIDE FROM AEROSOL COMPONENTS - The present invention provides an encapsulation technology and methods of using the encapsulation technology in processes involving the conversion of carbon monoxide to carbon dioxide. | 2009-04-02 |
20090087364 | EXHAUST GAS PURIFYING APPARATUS FOR INTERNAL COMBUSTION ENGINE - An exhaust gas purifying apparatus for an internal combustion engine is provided with a NOx removing device and a particulate filter in an exhaust system. A temperature of the exhaust system is detected. A switching control is performed for alternately performing a process for removing sulfur oxide accumulated in said NOx removing device and a regeneration process for burning particulates trapped in said particulate filter, when it is determined to be necessary to perform at least one of the removal of the sulfur oxide in said NOx removing device and the regeneration of the particulate filter. The switching control is performed according to the detected exhaust system temperature. | 2009-04-02 |
20090087365 | REMOVAL OF PARTICULATES FROM THE EXHAUST GAS OF INTERNAL COMBUSTION ENGINES OPERATED WITH A PREDOMINANTLY STOICHIOMETRIC AIR/FUEL MIXTURE - The exhaust gas of internal combustion engines operated with a predominantly stoichiometric air/fuel mixture contains, as well as the gaseous hydrocarbon (HC), carbon monoxide (CO) and nitrogen oxide (NO | 2009-04-02 |
20090087366 | Solvent for Separating Acid Gas Components from Technical Gases - The invention relates to the use of a liquid, containing 0.1 to 100% of an amine or several amines of formula H | 2009-04-02 |
20090087367 | Ammonia Oxidation Catalyst for Power Utilities - The present invention is directed to a method for removal by oxidation of the excess ammonia (NH | 2009-04-02 |
20090087368 | Configurations And Methods For Removal Of Mercaptanes From Feed Gases - A sulfur species-containing feed gas is processed in a treatment plant in which COS is hydrolyzed, and in which so produced hydrogen sulfide and other sulfur species are absorbed in a lean hydrocarbon liquid. The sulfur species in the so formed rich hydrocarbon liquid are then subjected to catalytic conversion into disulfides, which are subsequently removed from the rich solvent. Most preferably, sulfur free lean solvent is regenerated in a distillation column and/or refinery unit, and light components are recycled from the rich hydrocarbon liquid to the absorber. | 2009-04-02 |
20090087369 | FLUOROAPATITE DRIED PARTICLES AND ADSORPTION APPARATUS - Fluoroapatite dried particles are obtained by reacting hydroxyapatite primary particles having hydroxyl groups and hydrogen fluoride molecules having fluorine atoms so that at least one of hydroxyl groups of hydroxyapatite primary particles are substituted by the fluorine atoms of the hydrogen fluoride molecules. The fluoroapatite dried particles can exhibit superior acid resistance. Further, an adsorption apparatus using such fluoroapatite dried particles is provided. | 2009-04-02 |
20090087370 | METHOD AND MATERIAL FOR PURIFYING IRON DISILICIDE FOR PHOTOVOLTAIC APPLICATION - A method for processing iron disilicide for manufacture photovoltaic devices. The method includes providing a first sample of iron disilicide comprising at least an alpha phase entity, a beta phase entity, and an epsilon phase entity. The method includes maintaining the first sample of iron disilicide in an inert environment and subjects the first sample of iron disilicide to a thermal process to form a second sample of iron disilicide. The second sample of iron disilicide comprises substantially beta phase iron disilicide and is characterized by a first particle size. The method includes introducing an organic solvent to the second sample of iron disilicide, forming a first mixture of material comprising the second sample of iron disilicide and the organic solvent. The method processed the first mixture of material including the second sample of iron disilicide using a grinding process. The method converted the second sample of iron disilicide having the first particle size to a third sample of iron disilicide having a second particle size. The organic solvent is removed and output a third sample of iron disilicide characterized by the second particle size and greater than about 90% of the beta phase entity. | 2009-04-02 |
20090087371 | Apparatus for manufacturing carbon nanotubes and method of manufacturing carbon nanotubes with the same - Provided are an apparatus for manufacturing carbon nanotubes and a method of manufacturing carbon nanotubes with the apparatus. A plurality of carbon-nanotube-synthesizing units are disposed in series to continuously perform a carbon-nanotube-synthesizing process. Thus, carbon nanotubes having a uniform quality can be synthesized. | 2009-04-02 |
20090087372 | PROCESS FOR THE PREPARATION OF A CATALYST FOR THE PRODUCTION OF CARBON NANOTUBES - A process for the preparation of a catalyst for the production of carbon nanotubes, the use of the catalyst for the production of carbon nanotubes, and the carbon nanotubes obtained by this production process. The catalyst is prepared on the basis of at least two metals from the group: cobalt, manganese, iron, nickel and molybdenum from soluble precursor compounds by spray drying or spray granulation of the precursor compounds dissolved in a solvent, and subsequent calcination. | 2009-04-02 |
20090087373 | Method and Apparatus for Producing a Carbon Based Foam Article Having a Desired Thermal-Conductivity Gradient - A carbon based foam article is made by heating the surface of a carbon foam block to a temperature above its graphitizing temperature, which is the temperature sufficient to graphitize the carbon foam. In one embodiment, the surface is heated with infrared pulses until heat is transferred from the surface into the core of the foam article such that the graphitizing temperature penetrates into the core to a desired depth below the surface. The graphitizing temperature is maintained for a time sufficient to substantially entirely graphitize the portion of the foam article from the surface to the desired depth below the surface. Thus, the foam article is an integral monolithic material that has a desired conductivity gradient with a relatively high thermal conductivity in the portion of the core that was graphitized and a relatively low thermal conductivity in the remaining portion of the foam article. | 2009-04-02 |
20090087374 | Processes for Producing Synthetic Pyrite - Process of making high purity, synthetic FeS | 2009-04-02 |
20090087375 | ActRIIB Fusion Polypeptides and Uses Therefor - Methods and compositions for inhibiting growth and differentiation factor-8 (GDF-8) activity in vitro and in vivo are provided. The methods and composition can be used for diagnosing, preventing, or treating degenerative disorders of muscle, bone, or glucose homeostasis. | 2009-04-02 |
20090087376 | Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease - The present invention relates to the identification of compounds that are suitable for imaging amyloid deposits in living patients. The invention relates, in part, to a method of imaging amyloid deposits in brain in vivo to allow antemortem diagnosis of Alzheimer's disease. The present invention also relates to therapeutic uses for such compounds, as exemplified by compounds of the formula (1) in which Y is independently S, O, or N and m is 1, 2, or 3. | 2009-04-02 |
20090087377 | COMPOSITIONS FOR TARGETED IMAGING AND THERAPY - The present invention relates to the field of radiochemistry, nuclear imaging, radionuclide therapy and chemical synthesis. More particularly, it concerns a strategy for radiolabeling target ligands. It further concerns methods of using those radiolabeled ligands for imaging, radionuclide therapy and tissue-specific disease imaging. | 2009-04-02 |
20090087378 | Positron Tomography Method and Positron-Emitting Compound to Be Used Therein - It is an objective of the present invention to provide a positron tomography method applicable to the diagnosis of specific brain diseases and to provide a positron-emitting compound for use in the method. The present invention method relates to a positron tomography method for measuring a distribution and concentration of a positron-emitting source, and is characterized in using the compound (I) as the positron-emitting source. | 2009-04-02 |
20090087379 | Radiofluorinated Compounds and their Preparation - The present invention provides a process for [18F]-fluorination of biomolecules containing a primary amino group such as proteins and peptides and in particular of peptides. The invention further provides reagents for this process, in particular 18F-labelled prosthetic groups for use in the preparation as well as non-labelled intermediates useful in the preparation of the [18F]-labelled prosthetic groups. [18F]-labelled compounds useful as radiopharmaceuticals, specifically for use in Positron Emission Tomography (PET) are also provided. | 2009-04-02 |
20090087380 | Polymer devices for therapeutic applications - Multi-layered polymer devices having three-dimensional containers for holding a therapeutic and/or imaging agent are provided. The devices have a high loading ratio of agent to polymer material for effective treatment. Delivery wings or regions with channels connected to the containers are also incorporated in the devices. The delivery wings can be flexible and insertable into hollow instruments, such as a needle. Anchoring structures are also provided for fixing the position of the device after injection into a subject. The polymer layers of the device can be biodegradable. Biodegradable materials can also be used to provide controlled release of agents, such as for immunizations and other therapeutic or non-therapeutic applications. | 2009-04-02 |
20090087381 | CHELATOR-FUNCTIONALIZED NANOPARTICLES - Provided herein are chelator-functionalized nanoparticles comprising a passive core; and an active coating that demonstrate T1 magnetic resonance pattern upon exposure to a magnetic field. Also provided are methods of making such chelator-functionalized nanoparticles as well as imaging methods using the nanoparticles. | 2009-04-02 |
20090087382 | CONTRAST AGENTS AND METHODS FOR PREPARING CONTRAST AGENTS - Contrast agents comprising a scaffold protein having at least one operative integrated metal ion binding site. | 2009-04-02 |
20090087383 | NANOPARTICLE-BASED IMAGING AGENTS FOR X-RAY/COMPUTED TOMOGRAPHY AND METHODS FOR MAKING SAME - The present invention is generally directed to core/shell nanoparticles, wherein such core/shell nanoparticles comprise a nanoparticle core and a nanoshell disposed about the nanoparticle core such that, in the aggregate, they form a core/shell nanoparticle that is operable for use as an imaging agent in X-ray/computed tomography (CT). Typically, such core/shell nanoparticle-based X-ray CT imaging agents further comprise a targeting species for targeting the imaging agent to diseased sites. Included herein are methods for forming such agents, comprising forming an ensemble of core/shell nanoparticles, wherein the mean diameter of the ensemble of core/shell nanoparticles is selected so as to render the nanoparticles in the ensemble substantially clearable by a mammalian kidney. | 2009-04-02 |
20090087384 | MEDICINE AND METHOD FOR TREATMENT OF PROSTATE CANCER - The invention concerns a medicine for treatment of prostate cancer and a corresponding treatment method. The medicine can be supplied to a prostate tumor through the bloodstream, contains an active component and a binding component as well as ultrasound microbubbles. The binding component includes coupling molecules that specifically bind to a determined target molecule formed in the endothelium of tumor-associated blood vessels and that is typical of the tumor or the tumor stage. The active component contains at least one chemotherapeutic substance. The coupling molecules are bound to the outside of the microbubbles and active substance molecules are likewise bound to the outside of the microbubbles or are enclosed by the microbubbles. | 2009-04-02 |
20090087385 | Intranasally administering curcumin in a bolus of helium gas to treat alzheimers disease - Intranasally administering curcumin prodrugs and curcumin hybrids in a bolus of helium gas to the brain to treat Alzheimer's Disease | 2009-04-02 |
20090087386 | EFFERVESCENT COMPOSITION AND METHOD OF MAKING AN EFFERVESCENT COMPOSITION INCLUDING A VISCOUS COMPONENT - Disclosed is an effervescent composition and a method of making an effervescent composition that includes a viscous component and is a free flowing granulation. | 2009-04-02 |
20090087387 | ACETALS OF NEPETALIC ACID AND METHOD OF PREPARATION - Disclosed are acetals of nepetalic acid. They may be prepared by reaction of an alcohol with nepetalic acid, and are useful as repellents for insects and arthropods, in addition to other uses. | 2009-04-02 |
20090087388 | IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE - The invention provides novel immune regulatory oligonucleotides (IRO) as antagonist of TLRs and methods of use thereof. These IROs have unique sequences that inhibit or suppress TLR-mediated signaling in response to a TLR ligand or TLR agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, allergy, asthma or a disease caused by a pathogen. | 2009-04-02 |
20090087389 | DEHYDROEPIANDROSTERONE SULFATE DIHYDRATE INHALATION COMPOSITIONS AND METHODS - The invention relates to inhalation compositions derived from dehydroepiandrosterone sulfate. The compositions of the invention involve liquid nebulizer formulations prepared from dehydroepiandrosterone sulfate dihydrate. The compositions of the invention comprise water and chloride ion. The liquid nebulizer formulations can be used to treat patients suffering from asthma or COPD. | 2009-04-02 |
20090087390 | Fluidized slurry of water soluble and or water-swellable polymer and mixture thereof (FPS) for use in dentifrice and household applications - An oral care or household cleaner system contains a fluid polymer suspension (FPS) thickening agent. The FPS thickening agents comprises a water soluble/water swellable polymer, a polyol, and a hydrated thickening silica. The water soluble/water swellable polymer is selected from the group consisting of acrylic acid polymer, salts of acrylic acid polymer, acrylate, acrylamide polymer, polyvinyl pyrolidene, polyvinyl alcohol, clay and polysaccharide, excluding CMC. The functional systems may be formulations of oral care, for example as a dentifrice or as a household cleaner. A method of preparing the oral care or household cleaner system is also provided by adding a sufficient amount of a FPS that is compatible with the functional system to the system to thicken the functional system. | 2009-04-02 |
20090087391 | FOAMABLE FLUORIDE ORAL CARE COMPOSITION - A dental fluoride foam composition comprising an aqueous solution of a water soluble fluoride ion releasable salt, a surfactant selected from the group consisting of nonionic surfactants, zwitterionic surfactants, betaine surfactants and mixtures thereof; and an orally compatible acidifying agent in an amount sufficient to adjust the pH of the composition to about 3 to about 5. The composition is stable at low temperatures and is a clear solution substantially free of precipitates when held at 4.4° C. for 12 hours. When dispensed from a container into the trough of a dental tray, the composition forms a low density, rapidly collapsible foam which substantially liquefies in about 1 minute after being dispensed from the foam generating container and placed in contact with a patient's teeth. | 2009-04-02 |
20090087392 | Acid-neutralizing agent - Acid-neutralizing agent contains substantial amount of calcium of an acid-neutralizing ability against various acid chemicals substance for humans, animals, agricultural produces, meat and poultry. And the method of producing the same are provided. An environmental friendly high speed and high press scraping treatment is applied to a calcium-containing substance represented by calcium carbonate-containing substances originating from shellfishes, to eliminate heavy metals and other contamination accumulated on the surface. A heating and baking treatment is applied separately to the different said shellfishes and calcium carbonate-containing minerals and charcoal of bamboo to the temperature and maintaining the temperature not less then the decompose point of each calcium component-containing substance, a sufficient time of heating and baking treatment from 3 hours up to 18 hours depend on materials treated. An ionization and stabilization process is applied to the decomposed calcium components substance in high temperature. A regular pulverizing process is applied to grind the said calcium-containing substance into 500 mesh sizes of powder. A Nano pulverizing process is applied to the said powder into sizes not larger then 18000000 mesh (size of Nano). A formulation process is applied to the different pulverized calcium containing powder in different percentage to formulas which suitable for different applications. | 2009-04-02 |
20090087393 | Dental Treatment Compositions and Conformable Dental Treatment Trays Using the Same - The present invention is a formable dental treatment tray utilizing poly(2-ethyl-2-oxazoline) and a gelatinous active. Blending of the active is accomplished by mixing the Poly(2-ethyl-2-oxazoline) with an active ingredient, such as a peroxide like hydrogen peroxide, carbamide peroxide, sodium perborate, or sodium percarbonate, usually also with water or an appropriate organic solvent. Peroxide concentrations in these new gels can reach a 30% concentration of hydrogen peroxide while maintaining a shelf life of six months at room temperature without developing peroxide decomposition. The gels are applied to an appropriate backing and dried to a gelatinous state. In use, the active is hydrated and regains adhesiveness. Then the tray is pressed and formed around a user's dental arch to form the customizable tray. Multiple active ingredients may be used, with or without peroxide, for accomplishing desired treatment regimens. | 2009-04-02 |
20090087394 | PHOTOSTABILIZATION OF OCTYL TRIAZONE - Methods and compositions useful in enhancing protection from UV radiation, the compositions containing octyl triazone and diethylthexyl syringylidene malonate in an amount effective to photostabilize octyl triazone. | 2009-04-02 |
20090087395 | COMPOSITIONS FOR USE IN DARKENING THE SKIN - The present invention features a polymer for darkening the skin. The polymer comprises repeating units derived from melanin precursors and amine-comonomers. The polymer may be combined with a cosmetically acceptable carriers to form topical compositions. Methods of darkening the skin are also provided. | 2009-04-02 |
20090087396 | Sweat-Absorbing Cosmetic Product and Method for the Production Thereof - The invention relates to a preferably water-free sweat-absorbing cosmetic product, e.g. an antiperspirant, containing a base formulation and a sweat-absorbing complex. The invention also relates to a method for the production of said complex and said cosmetic product. | 2009-04-02 |
20090087397 | Mascara Composition - Mascara compositions containing a keratin conditioning agent, alone or in combination with an emollient/moisturizing agent, provide increased resistance of eyelash hair fibers to breaking. Low viscosity mascara composition of the invention containing low concentrations of surfactant and wax are easily removable from the eyelashes. Mascara compositions of the invention reduce eyelash damage and though having low viscosity (as compared to typical prior art compositions) surprisingly provide excellent buildup, lengthening and wear. | 2009-04-02 |
20090087398 | Method for Treating Damaged Hair - The present invention relates to a method for treating damaged hair, where the hair is chemically treated, comprising the steps of: a) contacting the hair with a shampoo composition, the shampoo comprising: from about 5% to about 50% of an anionic surfactant; from about 0.025% to about 5% by weight of a synthetic cationic polymer having a cationic charge density from about 2 meq/gm to about 7 meq/gm, wherein the synthetic cationic polymer forms lyotropic liquid crystals upon combination with the anionic surfactant; and water; and b) rinsing the composition from the hair, wherein following the treatment, the surface energy of the hair is reduced, as compared to that measured prior to the treatment. | 2009-04-02 |
20090087399 | POLYSILOXANE BLOCK COPOLYMERS - The invention relates to polysiloxane block copolymers of the formula A[LB(S)Q] | 2009-04-02 |
20090087400 | BREATHABLE POLYURETHANES, BLENDS, AND ARTICLES - A hair fixative composition containing a breathable polyurethane having an upright moisture vapor transmission rate (MVTR) of more than about 500 gms/m | 2009-04-02 |
20090087401 | DEODORANT COMPOSITION - It is intended to provide a novel deodorant composition which is excellent in the deodorizing effect, is capable of affording a deodorant composition by a convenient method, and shows no decrease in the deodorizing performance even after a long period of time, once the deodorant being prepared. Specifically, there is provided a deodorant composition containing, as the active component, a colored compound obtainable by reacting a polyphenol in a solvent showing alkalinity in the coexistence of an oxygen molecule at a reaction pH value of 6.5 or more. As a substitute for a polyphenol, use can be made of a plant extract containing a polyphenol but containing substantially no amino acid. It is also possible to further employ an amino acid. Furthermore, use can be made of a plant extract and/or a plant body containing a polyphenol and an amino acid. | 2009-04-02 |
20090087402 | Cyclopropanated Macrocyclic Ketones and Lactones - The present invention is directed to novel cyclopropanated macrocyclic ketone and lactone compounds of the general formula: | 2009-04-02 |
20090087403 | REVERSAL OF VIRAL-INDUCED SYSTEMIC SHOCK AND RESPIRATORY DISTRESS BY BLOCKADE OF THE LYMPHOTOXIN BETA PATHWAY - This invention provides methods of inducing an antiviral response in an individual comprising administering to the individual an effective amount of a LT-B blocking agent and a pharmaceutically acceptable carrier. In particular this invention provides methods for treating viral-induced systemic shock and respiratory distress. | 2009-04-02 |
20090087404 | METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY - Methods for treating cancer by co-administering a therapeutic monoclonal antibody with IL-21 are described. Exemplary monoclonal antibodies that can be used are rituximab, trastuzumab and anti-CTLA-4 antibodies. The enhanced antitumor of the combination therapy is particularly useful for patient populations that are recalcitrant to monoclonal therapy, relapse after treatment with monoclonal antibodies or where the enhanced IL-21 antitumor effect reduces toxicities associated with treatment using the monoclonal antibodies. | 2009-04-02 |
20090087405 | Use of Lck inhibitors for treatment of immunologic diseases - The invention relates to a method of treating immunologic diseases or pathological conditions involving an immunologic component using certain Lck inhibitors already known as kinase inhibitors for therapy in oncology, optionally in combination with one or more other drugs selected from NSAIDs, steroids, DMARDs, immunsuppressives, biologic response modifiers and antinfectives, pharmaceutical compositions comprising said Lck inhibitors together with said other drugs, and the use of the Lck inhibitors for the manufacture of a pharmaceutical composition for the treatment of immunologic diseases or pathological conditions involving an immunologic component. | 2009-04-02 |
20090087406 | REVERSE MICELLES BASED ON PHYTOSTEROLS AND ACYLGLYCEROLS AND THERAPEUTIC USES THEREOF - The present invention relates generally to reverse-mice liar system comprising a hydrosoluble therapeutically active agent. Reverse micelles according to the invention are particularly useful to deliver drugs. The present invention also relates to pharmaceutical composition comprising said reverse micelles and methods for preparing the same. | 2009-04-02 |
20090087407 | METHODS FOR THE TREATMENT OF SCLERODERMA USING 1-OXO-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-METHYLISOINDOLINE - Methods of treating, preventing, correcting and/or managing skin diseases or disorders characterized by overgrowths of the epidermis, keratoses, scleroderma, cutaneous vasculitis, acne or wrinkles are disclosed. Specific embodiments encompass the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent. Specific second active ingredients are capable of affecting or inhibiting cell growth or proliferation, removing or improving acne scars, or reducing or correcting wrinkle lines. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed. | 2009-04-02 |
20090087408 | Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device - The present invention provides a suspension vehicle and suspension formulations deliverable from an implantable delivery device. In particular, the suspension vehicle of the present invention allows the formulation of beneficial agent suspensions that are stable over time at ambient and physiological temperatures. In addition, the beneficial agent suspensions formed using the suspension vehicle of the present invention allow controlled delivery of beneficial agent from an implanted delivery device over sustained periods of time, even when such delivery occurs at low flow rates, through a small-diameter delivery channel. Also included in the present invention are implantable delivery devices. | 2009-04-02 |
20090087409 | Viral Polymerase Inhibitors - An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: | 2009-04-02 |
20090087410 | TREATMENT OF HYPERSENSITIVITY - The present invention relates to a method for inhibiting a hypersensitivity reaction in a subject, wherein said method comprises administering an effective amount of chaperonin (10). | 2009-04-02 |
20090087411 | Long-acting interferons and derivatives thereof and methods thereof - A polypeptide and polynucleotides encoding same comprising carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to an IFN protein are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. | 2009-04-02 |
20090087412 | Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression - The present invention relates to cardiac hypertrophy. More particularly, the present invention defines the molecular events linking calcium stimulation to cardiac hypertrophy. More specifically, the present invention shows that Ca | 2009-04-02 |
20090087413 | SELF-COMPLEMENTARY AAV-MEDIATED DELIVERY OF INTERFERING RNA MOLECULES TO TREAT OR PREVENT OCULAR DISORDERS - The invention provides methods for delivering interfering RNA molecules to an eye of a patient to treat ocular disorders. In particular, the methods of the invention comprise the use of a self-complementary adeno-associated (scAAV) viral vector that can deliver an interfering RNA molecule to an eye of a patient to inhibit expression of a gene that is associated with an ocular disorder. | 2009-04-02 |
20090087414 | Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs - Disclosed herein are materials and methods for modulating an immunologically adverse response to an exogenous or endogenous immunogen, including a cell, tissue, or organ associated immunogen. An implantable material comprising cells, such as but not limited to endothelial cells, anchored or embedded in a biocompatible matrix can modulate an adverse immune or inflammatory reaction to exogenous or endogenous immunogens, including response to non-syngeneic or syngeneic cells, tissues or organs, exogenous immunogens or stimuli, as well as ameliorate an autoimmune condition. The implantable material can be provided prior to, coincident with, or subsequent to occurrence of the immune response or inflammatory reaction. The implantable material can induce immunological acceptance in a transplant patient, reduce graft rejection and reduce donor antigen immunogenicity. | 2009-04-02 |
20090087415 | Treatment of cardiovascular disorders using the cell differentiation signaling protein Nell1 - It has been identified in accordance with the present invention that Nell1 is essential for normal cardiovascular development by promoting proper formation of the heart and blood vessels. The present invention therefore provides therapeutic methods for treating cardiovascular disorders by employing a Nell1 protein or nucleic acid molecule. | 2009-04-02 |
20090087416 | B7-H3 AND B7-H4, NOVEL IMMUNOREGULATORY MOLECULES - The invention provides novel B7-H3 and B7-H4 polypeptides useful for co-stimulating T cells, isolated nucleic acid molecules encoding them, vectors containing the nucleic acid molecules, and cells containing the vectors. Also included are methods of making and using these co-stimulatory polypeptides. | 2009-04-02 |
20090087417 | METHODS FOR PROMOTING DOPAMINERGIC NEURONAL DEVELOPMENT BY USING NG4A-SUBFAMILY AND WNT-LIGANDS - Methods for promoting dopaminergic neuronal development and producing neural cells having a dopaminergic phenotype. Dopaminergic neural cells may be used for treating individuals having a neurodegenerative disease such as Parkinson's disease. Dopaminergic cells may be implanted into the brain of the individual, and/or dopaminergic neural development may be induced or enhanced in the brain of the individual. Methods comprise expressing a nuclear receptor of the NG4A subfamily, e.g. Nurr1, above basal levels within the cell and treating the cell with a Wnt ligand, thereby producing or enhancing proliferation, self-renewal, survival and/or dopaminergic induction, differentiation, survival or acquisition of a neuronal dopaminergic phenotype. The cell may be co-cultured with astrocytes or glial cells and may be contacted with an FGF growth factor. | 2009-04-02 |
20090087418 | Method for the Preparation of Anallergic Probiotic Bacterial Cultures and Related Use - The aim of the present invention is a method for the preparation of anallergic probiotic bacterial cultures. | 2009-04-02 |
20090087419 | LICORICE POLYPHENOL PREPARATION - This invention provides a highly concentrated licorice polyphenol preparation with high bioavailability. Further, this invention is intended to maintain high transparency of a composition without deterioration of the indigenous properties of an aqueous substance, even when such composition is added thereto. Such licorice polyphenol preparation comprises a hydrophobic licorice extract comprising licorice polyphenol as a primary component, medium-chain fatty acid triglyceride, and polyoxyethylene sorbitan fatty acid ester, and the ratio of the total weight of the hydrophobic licorice extract and medium-chain fatty acid triglyceride to the weight of polyoxyethylene sorbitan fatty acid ester is between 1:1 and 1:10. | 2009-04-02 |
20090087420 | STABLE SOLUTION OF REDUCED COENZYME Q - The present invention provides a composition of a practically usable solution capable of stably maintaining, against oxidation, reduced coenzyme Q, which has not been employed in practice so far because of being liable to undergo oxidation and hydrophobic, a method of preparing the solution and a method of storing the solution. A solution of reduced coenzyme Q which can be stored at a low temperature or room temperature over a long time can be prepared by coating reduced coenzyme Q with liposome made of refined soybean lecithin, etc, and solubilizing, or solubilizing or emulsifying reduced coenzyme Q by using a surfactant at a low temperature. | 2009-04-02 |
20090087421 | Novel Recombinant Staphylokinase Derivatives and the Preparations and Applications thereof - The present invention relates to the biotechnology field, more particularly, to novel recombinant staphylokinase (RGD/KGD-Sak) derivatives and the preparation the thereof. The derivatives, have a low polymerizing ability, low immunogenicity and a bifunctionality of thrombolytics and anticoagulant. Based on the line, structural analysis of the monomer and dimer of recombinant staphylokinases and their biochemical properties, we designed two novel bifunctional staphylokinase molecular structures. Mutant genes were constructed by PCR site-directed mutagenesis which were then recombined with a prokaryotic vector and used to transform | 2009-04-02 |
20090087422 | Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the same - The present invention relates to pharmaceutical compositions for treating diseases and conditions caused by ischemia. The pharmaceutical compositions contain a conjugate of a phospholipase (PL) polypeptide and a protein transduction domain (PTD). PLC-δ plays a major role in the regulation of cytosolic calcium levels. During myocardial ischemia, cytosolic calcium accumulation mediates pathogenic changes. According to the present invention, ischemic diseases or conditions leading to hypoxia in tissues, such as the heart and the brain, can be prevented or alleviated by administration of a PTD-PL conjugate. | 2009-04-02 |
20090087423 | Novel protein complex and use thereof - The present invention provides a novel binding protein, a preventive/therapeutic agent for cancer or neurodegenerative diseases, etc. Specifically, the substance that inhibits the binding of (a) a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 26, a partial peptide thereof, or a salt thereof and (b) a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 27 or SEQ ID NO: 29, a partial peptide thereof, or a salt thereof is useful as an agent for the prevention/treatment of, e.g., cancer, etc., and the substance that promotes the above binding is useful as an agent for the prevention/treatment of, e.g., neurodegenerative diseases, etc. | 2009-04-02 |
20090087424 | Modulating Retinal Pigmented Epithelium Permeaion By Inhibiting Or Activating VEGFR-1 - Described is a method for use of an agonist or an antagonist of VEGFR-1 in the treatment or prevention of diseases wherein disorders of the retinal pigment epithelium permeation are involved. | 2009-04-02 |
20090087425 | Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease - There is provided a pharmaceutical composition for treating respiratory disease comprising an NO-donating steroid and at least one bronchodilator. Also provided is a method for treating respiratory diseases associated with inflammation comprising administering an NO-donating steroid with at least one bronchodilator. Method of use of the combination of an NO-donating compound, and a steroid with at least one bronchodilator for treating respiratory disease is also provided. | 2009-04-02 |
20090087426 | Methods for Treatment of Allergic Asthma - Methods of treatment of allergic asthma with IgE antagonists, including anti-IgE antibodies, IgE variants, peptide antagonists, peptidomimetics and other small molecules, are described. | 2009-04-02 |
20090087427 | BIOLOGICAL MATERIALS AND USES THEREOF - The invention provides binding molecules, including antibody molecules which selectively bind to a cell surface antigen of a target cell, and wherein the binding molecules, on binding the cell surface antigen, induce apoptosis of the target cell. There is also provided methods of and pharmaceutical compositions for apoptosis induction and uses thereof. | 2009-04-02 |
20090087428 | ANTI-FC-GAMMA RIIB RECEPTOR ANTIBODY AND USES THEREFOR - The present application describes antibodies that selectively bind human FcγRIIB, with little or no binding to other human FcγRs, e.g., human FcγRIIA. The invention also provides isolated bispecific antibodies comprising an antibody that selectively binds FcγRIIB, and a second antibody that specifically binds an activating receptor. Various uses, including therapeutic uses, for those antibodies are also described, including administration with anti-tumor antibodies and methods of inhibiting immune responses and suppressing histamine release. | 2009-04-02 |